These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7034752)

  • 1. [Biochemical aspects of involuntary movements (author's transl)].
    Nakamura S; Kameyama M
    No To Shinkei; 1981 Dec; 33(12):1177-85. PubMed ID: 7034752
    [No Abstract]   [Full Text] [Related]  

  • 2. [Biochemical bases of Parkinson disease].
    Colucci d'Amato C; Puccini A; Cristillo A; Vizioli R
    Recenti Prog Med; 1984 Oct; 75(10):889-901. PubMed ID: 6151219
    [No Abstract]   [Full Text] [Related]  

  • 3. The neuropharmacology of abnormal involuntary movement disorders (the dyskinesias).
    Marsden CD
    Mod Trends Neurol; 1975; 6():141-66. PubMed ID: 127927
    [No Abstract]   [Full Text] [Related]  

  • 4. Biochemical neuropathology of Parkinson's disease.
    Javoy-Agid F; Ruberg M; Taquet H; Bokobza B; Agid Y; Gaspar P; Berger B; N'Guyen-Legros J; Alvarez C; Gray F
    Adv Neurol; 1984; 40():189-98. PubMed ID: 6695594
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacological basis of akinesia in Parkinson's disease.
    Narabayashi H
    J Neural Transm Suppl; 1983; 19():143-51. PubMed ID: 6583305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between bromocriptine and levodopa. Biochemical basis for an improved treatment for parkinsonism.
    Hutt CS; Snider SR; Fahn S
    Neurology; 1977 Jun; 27(6):503-10. PubMed ID: 577299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [L-dopa treatment in parkinsonism. Biochemical basis (author's transl)].
    Bieniowa A; Kolasa M; Reichowa J
    Przegl Lek; 1976; 33(4):463-7. PubMed ID: 1273343
    [No Abstract]   [Full Text] [Related]  

  • 8. [Biogenic amines to the pathophysiology of involuntary movements and cerebellar ataxia (author's transl)].
    Ando K
    Tanpakushitsu Kakusan Koso; 1981 Aug; 26(11):1772-80. PubMed ID: 6458067
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experimental findings and new aspects in extrapyramidal diseases].
    Birkmayer W
    Wien Z Nervenheilkd Grenzgeb; 1966; 23(1):128-39. PubMed ID: 4226878
    [No Abstract]   [Full Text] [Related]  

  • 10. [Neurochemical basis for pathological motor activity].
    Hole K
    Tidsskr Nor Laegeforen; 1974 Jan; 94(1):11-7. PubMed ID: 4362478
    [No Abstract]   [Full Text] [Related]  

  • 11. The clinical physiology of side effects in long-term L-DOPA therapy.
    Barbeau A
    Adv Neurol; 1974; 5():347-365. PubMed ID: 4155234
    [No Abstract]   [Full Text] [Related]  

  • 12. [Aminoacids transport in the brain (author's transl)].
    Piccoli F
    Riv Patol Nerv Ment; 1974 Aug; 95(4):267-76. PubMed ID: 4157159
    [No Abstract]   [Full Text] [Related]  

  • 13. [Findings of biochemical research on schizophrenia (author's transl)].
    Ackenheil M; Hippius H; Matussek N
    Nervenarzt; 1978 Nov; 49(11):634-49. PubMed ID: 31575
    [No Abstract]   [Full Text] [Related]  

  • 14. Recent advances in research on Parkinsonism.
    Rinne UK
    Acta Neurol Scand Suppl; 1978; 67():77-113. PubMed ID: 31053
    [No Abstract]   [Full Text] [Related]  

  • 15. Involuntary movements other than Parkinsonism: biochemical aspects.
    Curzon G
    Proc R Soc Med; 1973 Sep; 66(9):873-6. PubMed ID: 4281484
    [No Abstract]   [Full Text] [Related]  

  • 16. [Biochemical and clinical correlations in Parkinson's disease].
    Barbeau A
    Rev Neurol (Paris); 1972 Aug; 127(2):253-64. PubMed ID: 4603361
    [No Abstract]   [Full Text] [Related]  

  • 17. [Motor and psychomotor activity of striatal monoamines].
    Poirier LJ; Bédard P; Larochelle L
    Laval Med; 1970 Sep; 41(7):894-6. PubMed ID: 4994702
    [No Abstract]   [Full Text] [Related]  

  • 18. Involuntary movement disorders.
    Still CN
    Neurol Clin; 1984 Feb; 2(1):71-89. PubMed ID: 6239089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biochemical seizure mechanism in brain--in reference to neurotransmitters (author's transl)].
    Mori A
    No Shinkei Geka; 1979 Oct; 7(10):923-31. PubMed ID: 42857
    [No Abstract]   [Full Text] [Related]  

  • 20. Catecholamines and neurologic diseases (second of two parts).
    Moskowitz MA; Wurtman RJ
    N Engl J Med; 1975 Aug; 293(7):332-8. PubMed ID: 125386
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.